(13-291) Addressing Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Patients With Type 2 Diabetes Mellitus in a Commercial Self-Funded Health Plan Within an Integrated Health System
Wednesday, December 10, 2025
3:15 PM - 4:15 PM
Location: Bayside A, Level 1
Residency Program: MultiCare Tacoma General Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Washington
